Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Product Launch

Shelter Pharma Product Launch

Shelter Pharma launched FOLIMAN Folic Acid Tablets in international markets on May 11, 2026. This expansion into nutraceuticals aims to strengthen its global healthcare segment presence.

Source

BSE filing, BSE: 543963. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Shelter Pharma Ltd: key numbers

Share price
₹39.60
Market cap
₹68.52 Cr
Revenue (annual)
₹73.13 Cr
Net profit (annual)
₹9.03 Cr
P/E (TTM)
7.6×Sector 46.1×
Promoter holding
46.11%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Shelter Pharma Ltd

All →

Other product launch announcements

All →